Hepatocellular carcinoma: From diagnosis to treatment
- 5 March 2016
- journal article
- review article
- Published by Elsevier BV in Surgical Oncology
- Vol. 25 (2), 74-85
- https://doi.org/10.1016/j.suronc.2016.03.002
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trialTrials, 2012
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and TherapyAnnual Review of Medicine, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic reviewHepatology International, 2007
- Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular CarcinomaAnnals of Surgery, 2007
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002